|
2025
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations and pharmaceutical agents. |
|
|
P/S
|
Providing consumer product information relating to pharmaceuticals and pharmaceutical preparation... |
|
2021
|
P/S
|
Pharmaceuticals and pharmaceutical preparations, namely,
anti-infectives, anti-inflammatories, a... |
|
|
P/S
|
Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories ANTI-Fibrotic proper... |
|
2020
|
P/S
|
Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents. |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the aut... |
|
|
P/S
|
Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical prep... |
|
2019
|
P/S
|
Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; cardiovascular phar... |
|
2017
|
P/S
|
Pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease. |
|
|
P/S
|
Pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease |
|
|
P/S
|
Pharmaceuticals and pharmaceutical preparations. Scientific, biological, pharmaceutical and medic... |
|
2016
|
P/S
|
pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease |
|
|
Invention
|
Stable trientine formulations. Provided are pharmaceutical dosage forms comprising (i) trientine ... |
|
2004
|
P/S
|
Pharmaceutical preparations for use, through prescription,
in the treatment of chronic hepatitis C. |
|
|
Invention
|
Composition containing ribavirin and use thereof. Ribavirin formulations are disclosed for use in... |
|
|
Invention
|
Process for producing wet ribavirin pellets.
A process for producing wet ribavirin pellets is pr... |
|
2001
|
Invention
|
Process for producing wet ribavirin pellets. A process for producing wet ribavirin pellets is pro... |
